News
News
- Exactech CEO Dr. William Petty to Present at the Thomas Weisel Partners Healthcare Conference 2008 on September 3
- GAINESVILLE, Fla. -- August 25, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Thomas Weisel Partners 2008 Healthcare Conference on Wednesday, September 3, 2008 at 3:15 p.m. Eastern time.
- Exactech to Present at the 2008 Noble Financial Equity Conference on August 18
- GAINESVILLE, Fla. -- August 5, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Fourth Annual Noble Financial Equity Conference. The two-day conference will showcase 150 small cap public companies at the Loews Lake Las Vegas Resort, Nevada.
- Exactech Q2 Revenue Up 38% to $43.7M; Net Income $3.0M vs $1.4M
- GAINESVILLE, Fla. -- July 30, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that revenue for the second quarter of 2008 increased 38% to $43.7 million from $31.6 million in the second quarter of 2007. Diluted earnings per share for the quarter was $0.24 based on net income of $3.0 million. This compares with net income of $1.4 million or $0.12 diluted EPS a year ago.
- Exactech Awarded National Contract from HealthTrust Purchasing Group for Orthopaedic Products
- GAINESVILLE, Fla. -- July 29, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has been awarded a national purchasing contract by HealthTrust Purchasing Group (HealthTrust). This contract will cover the Equinoxe® Shoulder product line. The award is a three-year agreement that goes into effect August 1, 2008.
- Exactech Announces Q2 Earnings and Conference Call
- GAINESVILLE, Fla. -- July 16, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter earnings on Wednesday, July 30, after the market closes.
- Exactech Joins Russell 3000 Index
- GAINESVILLE, Fla. -- July 1, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it was added to the broad-market Russell 3000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes. The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The final membership list for the Russell 3000 has been posted at www.russell.com/Indexes/membership/default.asp.
- Exactech Awarded National Contract from HealthTrust Purchasing Group
- GAINESVILLE, Fla. -- June 18, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it was awarded a national purchasing contract by HealthTrust Purchasing Group, LP (HealthTrust). This contract will include primary and revision hip and knee implants, as well as InterSpace® cement spacers. The award is a five-year agreement that goes into effect July 15th.
- Exactech Signs New $40 Million Revolving Line of Credit
- GAINESVILLE, Fla. -- June 16, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has signed a new $40 million syndicated line of credit.
- Exactech Expands Total Hip Replacement Offerings with Full Market Release of Novation® Crown Cup System
- GAINESVILLE, Fla. -- June 13, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the full-market release of the Novation® Crown Cup® Acetabular System, the latest component of the Novation Comprehensive Hip System.
- Exactech Announces Leadership Promotions
- GAINESVILLE, Fla. -- June 3, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today several key leadership promotions.
- Exactech Completes Previously Announced Sale of Common Stock
- GAINESVILLE, Fla. -- May 14, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has closed its previously announced sale of 877,391 shares of its common stock to certain institutional investors at a price of $23.00 per share. The sale resulted in gross proceeds of approximately $20.2 million and net proceeds of approximately $18.8 million after offering expenses and placement agency fees. Exactech offered the shares pursuant to an effective registration statement previously filed with the Securities and Exchange Commission.
- Exactech Announces Sale of Common Stock Resulting in $20.2 Million in Gross Proceeds
- GAINESVILLE, Fla. -- May 9, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has entered into definitive agreements with certain institutional investors to sell 877,391 shares of its common stock at a price of $23.00 per share, resulting in gross proceeds of approximately $20.2 million and net proceeds of approximately $18.8 million after offering expenses and placement agency fees. Exactech offered the shares pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. The offering is expected to close on or before May 14, 2008 and is subject to certain closing conditions.
- Exactech Q1 Revenue Increases 34% to $39.8 Million
- GAINESVILLE, Fla. -- April 29, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $39.8 million for the first quarter of 2008, an increase of 34% compared to $29.6 million for the first quarter of 2007. Net income for the quarter was $2.8 million, or $0.23 per diluted share, a gain of 49% from the $1.9 million, or $0.16 per diluted share, in the same quarter a year ago. First quarter diluted earnings per share included a gain of $0.03 due to a forward currency call option and a loss of $0.01 per share due to Exactech’s minority investment in Altiva prior to the acquisition.
- Exactech Increases Q1 and FY’08 Financial Guidance
- GAINESVILLE, Fla. -- April 10, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it expects to report revenue of approximately $40.0 million for the first quarter of 2008, an increase of 35% compared to $29.6 million for the first quarter of 2007. Diluted earnings per share for the first quarter is expected to range from $0.22 to $0.24 compared with $0.16 diluted earnings per share in the same quarter a year ago. First quarter earnings include a gain of $0.03 due to a forward currency call option.
- Exactech Closes France Medica Acquisition
- GAINESVILLE, Fla. -- April 7, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that, effective April 1, 2008, it closed on the acquisition of the stock and assets of France Medica SAS, a French importer and distributor of orthopaedic products and surgical supplies.
- Exactech Names Industry Veteran Daniel Berdat as VP of International Sales and Marketing
- GAINESVILLE, Fla. -- April 1, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the appointment of Daniel Berdat as Vice President of International Sales and Marketing, effective April 1.
- Exactech Signs License Agreement for Cartilage Repair Technology, Patent Rights
- Gainesville, Fla. -- March 4, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today its Taiwanese subsidiary, Exactech Taiwan, has entered into an exclusive license agreement with the Industrial Technology Research Institute (ITRI) and the National Taiwan University Hospital (NTUH) for the rights to technology and patents related to the repair of cartilage lesions.
- Exactech to Host Financial Analyst Meetings at AAOS, Present at Orthopaedics Financial Conference
- Gainesville, Fla. -- March 3, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced it will host financial analyst meetings in conjunction with the company’s display for surgeons during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco March 5 through March 7.
- Exactech 2007 Revenue Up 21% to $124.2M; Net Income $8.5M or $0.72 EPS
- Gainesville, Fla., -- February 28, 2008 -- Exactech, Inc. (Nasdaq: EXAC) announced today that revenue for fiscal year 2007 increased 21% to $124.2 million from $102.4 million in 2006. Net income for the year increased 9% to $8.5 million or $0.72 diluted earnings per share for the year, compared with net income of $7.8 million or $0.67 diluted earnings per share during 2006. Excluding an impairment charge after taxes of $977,000, related to diamond technology previously announced, net income for 2007 was $9.5 million, an increase of 22%, and diluted earnings per share was $0.80 for 2007 compared to $0.67 in 2006.
- Exactech to Acquire Distribution Company in France; Opens Direct Distribution Operations in Japan
- GAINESVILLE, Fla. -- February 27, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the opening of a wholly-owned distribution subsidiary in Japan and the planned acquisition of a distribution subsidiary in France.
